Epodion (epoetin alfa biosimilar) / Daewoong Pharma, Asia-Pharma - LARVOL DELTA

Conventional and complementary alternative medicine therapies for renal anemia: a literature review. (PubMed, Front Endocrinol (Lausanne)) - "The article details the effects of Roxadustat, Ferumoxytol, and Epodion. Clinical trials suggest that CAM therapy can improve renal anemia through mechanisms such as enhanced iron metabolism, anti-inflammatory effects, reduced hepcidin levels, and increased EPO and HIF expressions. By synthesizing this information, the review aims to furnish valuable insights and treatment recommendations aimed at ameliorating renal anemia in individuals grappling with chronic kidney disease."

Journal • Review • Anemia • Chronic Kidney Disease • Fatigue • Hematological Disorders • Inflammation • Nephrology • Renal Disease

Comparative Study of Recombinant Human Erythropoietin (rhEPO) Products on CKD (Chronic Kidney Disease) Patients. (PubMed, Drug Res (Stuttg)) - "This study proves that the efficacy indicated by the change instability of Hb and safety indicated by adverse event incidence of Epodion and the reference product on chronic kidney disease were similar."

Journal • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease

Cohort Prospective Study to Evaluate Immunogenicity of Epodion® (Biosimilar Epoetin-a) in Anemia Associated with Chronic Kidney Disease (CKD) Patients. (PubMed, Acta Med Indones) - "This study proves no immunogenic effect of Epodion on stimulating immune system's antibodies in Indonesian patients with CKD-associated anemia."

Clinical • Journal • Anemia • Chronic Kidney Disease • Hematological Disorders • Nephrology • Renal Disease